153 results
Page 3 of 8
8-K
EX-99.1
lx375jap7r quny
6 Aug 19
Results of Operations and Financial Condition
8:15am
8-K
EX-99.1
13jx7 k79vb
1 May 19
Alnylam Pharmaceuticals Reports First Quarter 2019 Financial Results and Highlights Recent Period Activity
8:45am
PRER14A
njyrj
18 Mar 19
Preliminary revised proxy
5:24pm
PRE 14A
a5ek syklnloigp1
11 Mar 19
Preliminary proxy
5:07pm
8-K
EX-99.1
e7fygfz3oho q1g3tnz
7 Feb 19
Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Highlights Recent Period Activity
4:15pm
8-K
EX-1.1
184j0h vyc
15 Jan 19
Entry into a Material Definitive Agreement
5:19pm
424B5
huf laib3vcoo5nstyw5
15 Jan 19
Prospectus supplement for primary offering
5:14pm
424B5
1kq41 w6u
14 Jan 19
Prospectus supplement for primary offering
4:41pm
8-K
EX-99.1
lufzd
10 Aug 18
ONPATTROâ„¢ (patisiran) for the Treatment of the Polyneuropathy of Hereditary
3:45pm
8-K
EX-99.1
1esorwsfiagwxi
3 May 18
Alnylam Pharmaceuticals Reports First Quarter 2018 Financial Results and Highlights Recent Period Activity
4:15pm